BEGIN:VCALENDAR
VERSION:2.0
PRODID:ADNA Events System
X-WR-TIMEZONE:America/Toronto
BEGIN:VTIMEZONE
TZID:America/Toronto
X-LIC-LOCATION:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0400
DTSTART:19810329T020000
RRULE:FREQ=YEARLY;INTERVAL=1;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:69e8df43ba856
DTSTART;TZID=America/Toronto:20260506T200000
SEQUENCE:0
TRANSP:OPAQUE
DTEND;TZID=America/Toronto:20260506T210000
URL:https://secure.cas.ca/events/index.html/event-info/details/id/67
SUMMARY:CAS SAMBA Round - Contemporary Pharmacology in Ambulatory Anesthesi
 a: Focus on Remimazolam and Beyond
CLASS:PUBLIC
DESCRIPTION:\n\nhttps://secure.cas.ca/events/index.html/event-info/details/
 id/67
X-ALT-DESC;FMTTYPE=text/html:<p>This session will provide a focused update 
 on&nbsp\;<strong>contemporary pharmacology in ambulatory anesthesia</stron
 g>\, with particular emphasis on&nbsp\;<strong>remimazolam</strong>\, a no
 vel ultrashort-acting benzodiazepine with growing clinical applications in
  procedural sedation and general anesthesia. The discussion will highlight
  its pharmacologic profile\, clinical advantages\, and practical considera
 tions in comparison with established agents.</p>\n\n<p>In addition\, the s
 ession will briefly review other important pharmacologic developments rele
 vant to current practice\, including&nbsp\;<strong>GLP-1 receptor agonists
  and their perioperative implications\, intravenous amisulpride for postop
 erative nausea and vomiting\, and sugammadex for neuromuscular blockade re
 versal</strong>. Emerging concepts in analgesic pharmacology will also be 
 introduced\, offering a glimpse into potential future directions in periop
 erative care.</p>\n\n<p>After attending this round\, participants will be 
 able to:</p>\n\n<ol>\n<li>Review the pharmacology\, mechanism of action\, 
 and clinical applications of remimazolam in ambulatory anesthesia and proc
 edural sedation\, including its role in adult and pediatric practice.</li>
 \n<li>Discuss contemporary advances in perioperative pharmacology relevant
  to ambulatory anesthesia\, including GLP-1 receptor agonists\, intravenou
 s amisulpride for prevention and rescue treatment of postoperative nausea 
 and vomiting\, and sugammadex for neuromuscular blockade reversal.</li>\n<
 li>Describe future directions in anesthetic pharmacology and perioperative
  analgesia\, including novel opioid compounds currently in preclinical dev
 elopment and their potential implications for safer pain management.</li>\
 n</ol>\n
DTSTAMP:20260422T104627Z
END:VEVENT
END:VCALENDAR